Drugs

, Volume 40, Issue 3, pp 364–373

Current Treatment Recommendations for Topical Burn Therapy

  • William W. Monafo
  • Michael A. West
Practical Therapeutics

Summary

Infections in burn patients continue to be the primary source of morbidity and mortality. Topical antimicrobial therapy remains the single most important component of wound care in hospitalised burn patients. The goal of prophylactic topical antimicrobial therapy is to control microbial colonisation and prevent burn wound infection. In selected clinical circumstances topical agents may be used to treat incipient or early burn wound infections. At the present time silver sulfadiazine is the most frequently used topical prophylactic agent; it is relatively inexpensive, easy to apply, well tolerated by patients, and has good activity against most burn pathogens. In patients with large burns the addition of cerium nitrate to silver sulfadiazine may improve bacterial control. Mafenide acetate has superior eschar-penetrating characteristics, making it the agent of choice for early treatment of burn wound sepsis. However, the duration and area of mafenide application must be limited because of systemic toxicity associated with prolonged or extensive use. Other agents, such as nitrofurazone or chlorhexidine preparations, may be useful in isolated clinical situations. The undesirable side effects of silver nitrate solution limit its use by most clinicians at the present time.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bentivegna P. Silver sulphadiazine: an adjunct to central line maintenance protocol. Correspondence. Critical Care Medicine 18: 120, 1990PubMedCrossRefGoogle Scholar
  2. Bonder CC, Morris BJ, Wee T, Burke JF. The metabolic effects of 0.5% silver nitrate in the treatment of major burns in children. Journal of Pediatric Surgery 2: 22–31, 1967CrossRefGoogle Scholar
  3. Bowser-Wallace BH, Graves DB, Caldwell FT. An epidemiologic profile and trend analysis of wound flora in burned chidren: 7 years experience. Burns 11: 16–25, 1984CrossRefGoogle Scholar
  4. Burke JF, Quinby WC, Bondoc CC. Primary excision and grafting as routine therapy for the treatment of thermal burns in children. Surgical Clinics of North America 56: 477–494, 1976PubMedGoogle Scholar
  5. Chicarelli ZN, Cuono CB, Heinrich JJ, Fichlander BC, Barese S. Selective aggressive burn excision for high mortality subgroups. Journal of Trauma 26: 18–25, 1986CrossRefGoogle Scholar
  6. Constable JD, Morris BJ, Burke JF. Absorption of silver nitrate from open wounds. Plastic and Reconstructive Surgery 39: 342–349, 1967PubMedCrossRefGoogle Scholar
  7. Curreri WP. Burns. In Howard RJ & Simmons RL (Eds) Surgical infectious disease, pp. 873–881, Appleton Lange, Norwalk, 1988Google Scholar
  8. Deitch EA, Marino AA, Malakanok V, Albright JA. Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. Journal of Trauma 27: 301–304, 1987PubMedCrossRefGoogle Scholar
  9. Demling RH. Burns. New England Journal of Medicine 313: 1389–1398, 1985PubMedCrossRefGoogle Scholar
  10. Feller I, Tholen D, Cornell RG. Improvements in burn care, 1965–1979. Journal of the American Medical Association 244: 2074–2078, 1980PubMedCrossRefGoogle Scholar
  11. Fox CL. Silver sulfadiazine: a new topical therapy for Pseudomonas in burns. Archives of Surgery 96: 184–188, 1968PubMedCrossRefGoogle Scholar
  12. Fox CL, Monafo WW, Ayvazian VH, Skinner AM, Modak S, et al. Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surgery, Gynecology and Obstetrics 144: 668–672, 1977PubMedGoogle Scholar
  13. Fuller FW, Engler PE. Leukopenia in non-specific burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey. Journal of Burn Care and Rehabilitation 9: 606–609, 1988PubMedCrossRefGoogle Scholar
  14. Gray DT, Pine RW, Harnar TJ, Marvin JA, Engrav LH, et al. Early surgical excision versus conventional therapy in patients with 20–40 percent burns: a comparative study. American Journal of Surgery 144: 76–80, 1982PubMedCrossRefGoogle Scholar
  15. Harrison HN, Bales H, Jacoby F. The behavior of mafenide acetate as a basis for its clinical use. Archives of Surgery 103: 449–453, 1971PubMedCrossRefGoogle Scholar
  16. Harrison HN, Blackmore WP, Bales HW, Reeder W. The absorption of C14-labelled sulfamylon acetate through burned skin. 1. Experimental methods and initial observations. Journal of Trauma 12: 986–993, 1972PubMedCrossRefGoogle Scholar
  17. Heggers JP, Robson MC, Herndon DN, Desai MH. The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. Journal of Burn Care and Rehabilitation 10: 508–511, 1989PubMedCrossRefGoogle Scholar
  18. Hermans RP. Topical treatment of serious infections with special reference to the use of a mixture of silver sulfadiazine and cerium nitrate: two clinical studies. Burns 11: 59–62, 1984CrossRefGoogle Scholar
  19. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, et al. A comparison of conservative versus early excision: therapies in severely burned patients. Annals of Surgery 209: 547–553, 1989PubMedCrossRefGoogle Scholar
  20. Holder IA, Knoll CA, Wesselman J. Norfloxacin and silver norfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp. isolated from burn patients. Journal of Burn Care and Rehabilitation 7: 479–483, 1986PubMedCrossRefGoogle Scholar
  21. Hunt JL, Sato RM. Early excision of full thickness hand and digit burns: factors affecting morbidity. Journal of Trauma 22: 414–419, 1982PubMedCrossRefGoogle Scholar
  22. Hunt JL, Sato R, Heck EL, Baxter CR. A critical evaluation of povidone-iodine absorption in thermally injured patients. Journal of Trauma 20: 127–131, 1980PubMedCrossRefGoogle Scholar
  23. Lawrence JC, Cason JS, Kidson A. Evaluation of phenoxetol-chlorhexidine cream as a prophylactic agent in burns. Lancet 1: 1037–1049, 1982PubMedCrossRefGoogle Scholar
  24. Lindbergh RB, Moncrief JA, Mason AD. Control of experimental and clinical burn wound sepsis by topical application of Sulfamylon compounds. Annals of the New York Academy of Sciences 150: 950–972, 1968CrossRefGoogle Scholar
  25. McCauley RL, Linares HA, Pelligrini V, et al. In vitro toxicity of topical antimicrobial agents to human fibroblasts. Journal of Surgical Research 46: 267–274, 1989PubMedCrossRefGoogle Scholar
  26. McManus AT, Denton CL, Mason AD. Topical chlorhexidine diphosphanilate (WP-973) in burn wound sepsis. Archives of Surgery 119: 206–211, 1984PubMedCrossRefGoogle Scholar
  27. McManus AT, Moody EE, Mason AD. Bacterial motility: a component in experimental Pseudomonas aeruginosa burn wounsepsis. Burns 6: 235–239, 1980CrossRefGoogle Scholar
  28. Monafo WW, Mover CA. Effectiveness of dilute aqueous silver nitrate in the treatment of major burns. Archives of Surgery 91: 200–210, 1965CrossRefGoogle Scholar
  29. Moncrief JA. Topical therapy for control of bacteria in the burn wound. World Journal of Surgery 2: 151–165, 1978PubMedCrossRefGoogle Scholar
  30. Moncrief JA, Lindbergh RB, Switzer WE, Pruitt BA. Use of topical antibacterial therapy in the treatment of the burn wound. Archives of Surgery 92: 558–565, 1966PubMedCrossRefGoogle Scholar
  31. Moyer CA, Bretano L, Gravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5 percent silver nitrate solution. Archives of Surgery 90: 812–867, 1965PubMedCrossRefGoogle Scholar
  32. Munster AM. Treatment of invasive Enterobacter cloacae burn wound sepsis with topical nitrofurazone. Journal of Trauma 24: 524–525, 1984PubMedCrossRefGoogle Scholar
  33. Munster AM, Helvig E, Rowland S. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective evaluation. Surgery 88: 658–660, 1980PubMedGoogle Scholar
  34. Noble WC, Sommerville DA (Eds). Microbiology of human skin, Saunders, Philadelphia, 1974Google Scholar
  35. Order SE, Moncrief JA. The burn wound, pp. 36–45, Charles C. Thomas, Springfield, Illinois, 1965Google Scholar
  36. Peterson VM, Hansbrough JF, Wang XW, Zapata-Sirvent R, Boswick JA. Topical cerium nitrate cream prevents postburn immunosuppression. Journal of Trauma 25: 1039–1044, 1985PubMedCrossRefGoogle Scholar
  37. Pruitt BA, Goodwin CW. Thermal injuries. In Davis JH (Ed.) Clinical surgery, pp. 2823–2904, Mosby, St Louis, 1987Google Scholar
  38. Pruitt BA, Lindbergh RB. Pseudomonas aeruginosa infections in burned patients. In Dogget RG (Ed.) Pseudomonas aeruginosa, pp. 339–366, Academic Press Inc., New York, 1979Google Scholar
  39. Pruitt BA, McManus AT. Opportunistic infections in severely burned patients. American Journal of Medicine XX: 146–154, 1984CrossRefGoogle Scholar
  40. Rath T, Meissl G. Induction of hyperthyroidism in burn patients treated topically with povidone-iodine. Burns 14: 320–322, 1988CrossRefGoogle Scholar
  41. Rode H, de Wet PM, Millar AJ, Cywes S. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection. Journal of Antimicrobial Chemotherapy 21: 589–595, 1988PubMedCrossRefGoogle Scholar
  42. Schuck JM, Thorne LW, Cooper CG. Mafenide acetate solution dressings: an adjunct in burn wound care. Journal of Trauma 15: 595–599, 1975CrossRefGoogle Scholar
  43. Simmons RL, Ahrenholz DH. Infections of the skin and soft tissue. In Howard RJ & Simmons RL (Eds) Surgical infectious disease, pp. 337–441, Appleton Lange, Norwalk, 1988Google Scholar
  44. Smith-Choban P, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. American Surgeon 53: 515–517, 1987Google Scholar
  45. White MG, Asch MJ. Acid base effects of topical mafenide acetate in the burned patient. New England Journal of Medicine 284: 1281–1286, 1971PubMedCrossRefGoogle Scholar
  46. Yurt RW, McManus AT, Mason AD, Pruitt BA. Increased susceptibility to infection related to extent of burn injury. Archives of Surgery 119: 183–188, 1984PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1990

Authors and Affiliations

  • William W. Monafo
    • 1
    • 2
  • Michael A. West
    • 1
    • 2
  1. 1.Department of SurgeryWashington University School of MedicineSt Louis, MissouriUSA
  2. 2.Hennepin County Medical CenterMinneapolisUSA

Personalised recommendations